Uterine Cancer Therapeutics market report by 2021 Uterine Cancer Therapeutics market report by 2021 | Page 7

9.1.2 Product Analysis
9.1.3 Financial analysis
9.1.4 Recent Developments
9.1.5 SWOT analysis
9.1.6 Analyst View
9.2 Ariad Pharmaceuticals, Inc. (U.S.)
9.3 Becton, Dickinson and Company (U.S.)
9.4 F. Hoffmann-La Roche AG (Switzerland)
9.5 GlaxoSmithKline Plc (U.K.)
9.6 Merck & Co., Inc. (U.S.)
9.7 Novartis AG (Switzerland)
9.8 Sanofi (France)
9.9 Siemens Healthcare GmbH (Germany)
9.10 Takeda Pharmaceutical Company Ltd. (Japan)
10.Competitive Landscape
10.1 Market share analysis
10.2 Merger and Acquisition Analysis
10.3 Agreements, collaborations and Joint Ventures
10.4 New Product Launches
11.Market Outlook & Investment Opportunities
Appendix
a) List of Tables
b) List of Figures